Efficacy of minimally invasive pectopexy with concomitant I‐stop‐mini sling for women with pelvic organ prolapse and overt stress urinary incontinence: A retrospective cohort study

Abstract

AbstractObjectiveTo compare the efficacy of minimally invasive pectopexy with I‐stop‐mini (MPI) and minimally invasive sacrocolpopexy with Obtryx (MSO).MethodsWomen with pelvic organ prolapse quantification (POP‐Q) stage III or more and overt stress urinary incontinence from May 2018 to May 2021 were included. Patients with meshes fixed on the cervix or vaginal vault and bilateral pectineal ligament with I‐stop‐mini were classified into the MPI group, while those fixed on the apex and sacral promontory with Obtryx were classified into the MSO group. The primary outcomes were 1‐year‐postoperative POP‐Q stage, patient‐reported urinary and prolapse outcomes (Urogenital Distress Inventory‐6, International Consultation on Incontinence Questionnaire‐Short Form, and Pelvic Organ Prolapse Distress Inventory‐6), 1‐h pad test, and sexual life quality (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire). Secondary outcomes included operative data and adverse events.ResultsThe efficacy of MPI was similar to that of MSO according to the primary outcomes. MPI had shorter operative times (133.4 ± 30.6 min versus 199.3 ± 20.9 min, P = 0.001) and lower incidence rate of abdominal pain (0% vs 20%, P = 0.02) and groin pain (8% vs 40%, P = 0.01) than MSO.ConclusionsMPI showed similar efficacy to MSO, but demonstrated shorter operative times and lower incidence rates of abdominal and groin pain.